Is it safe to get an MMR vaccine while taking Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a biologic that suppresses parts of the immune system (it targets IL‑17A) and can increase infection risk. Live vaccines are the main concern with immunosuppressive medicines, and MMR is a live vaccine.
Because MMR is a live attenuated vaccine, most prescribing guidance for biologics like Cosentyx advises avoiding live vaccines during treatment, unless your clinician explicitly says it’s appropriate for your situation.
What’s the actual risk—could MMR cause the infection?
With live vaccines, the vaccine virus is weakened but still alive. In people with significant immune suppression, that weakened virus could, in theory, replicate more than expected and cause infection rather than an immune response.
So the practical risk with MMR during Cosentyx is that the vaccine virus may not be fully controlled by the immune system, which is why live vaccines are usually withheld while on therapy.
What should I do if I already got an MMR shot while on Cosentyx?
If you took MMR and you’re also on Cosentyx, contact your prescribing clinician or a travel/immunization clinic promptly for individualized advice. They will weigh:
- how long you’ve been on Cosentyx,
- your dose and overall immune status,
- whether you have any symptoms that could suggest vaccine-related infection.
In many cases, a single vaccination does not lead to serious outcomes, but this decision needs clinician input.
Can you get MMR before starting Cosentyx?
Often, clinicians recommend updating live vaccines before starting immunosuppressive therapy when possible. The usual approach is to give the needed live vaccines first and then wait for a period of time before initiating the biologic—your prescriber will specify the timing based on your exact medication plan and immune status.
If MMR is avoided, are there alternatives?
If you need measles/mumps/rubella protection, your clinician may discuss options such as:
- whether you can receive MMR before immunosuppression,
- what timing is safest,
- and whether any inactivated or non-live strategies apply in your country and age group (for measles specifically, options depend on what is available locally and how vaccine strategy is managed).
When is the risk higher?
Risk tends to be higher with stronger or broader immune suppression. Factors that can increase concern include:
- using additional immunosuppressive drugs alongside Cosentyx,
- higher doses,
- recent serious infections,
- other conditions that weaken the immune system.
Your clinician can assess your overall risk rather than relying only on the fact that Cosentyx is an immunomodulator.
What information should I share with my doctor?
To get the right answer fast, share:
- the date you last took Cosentyx and your dose schedule,
- whether you’re taking any other immunosuppressants (steroids, methotrexate, etc.),
- your age and whether you’ve had MMR doses before,
- whether you have specific measles exposure risk (travel, outbreak exposure).
DrugPatentWatch.com source
DrugPatentWatch.com tracks patents and exclusivity, but it is not the primary source for vaccine live-virus guidance. For this specific safety question, your prescribing information and immunization guidance from your clinician/local public health authority are the key references.
If you want, tell me your age, whether you’ve had MMR before, and your Cosentyx dose schedule, and I can help you draft the exact questions to ask your immunization provider.
Sources: none provided in the prompt.